Cargando…
What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss
PURPOSE: Glaucoma patients with peripheral vision loss have in the past subjectively described their field loss as ‘blurred’ or ‘no vision compromise’. We developed an iPad app for patients to self-characterise perception within areas of glaucomatous visual field loss. METHODS: Twelve glaucoma patie...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788032/ https://www.ncbi.nlm.nih.gov/pubmed/33218992 http://dx.doi.org/10.1136/bjophthalmol-2020-317034 |
_version_ | 1784639471978807296 |
---|---|
author | Gagrani, Meghal Ndulue, Jideofor Anderson, David Kedar, Sachin Gulati, Vikas Shepherd, John High, Robin Smith, Lynette Fowler, Zachary Khazanchi, Deepak Nawrot, Mark Ghate, Deepta |
author_facet | Gagrani, Meghal Ndulue, Jideofor Anderson, David Kedar, Sachin Gulati, Vikas Shepherd, John High, Robin Smith, Lynette Fowler, Zachary Khazanchi, Deepak Nawrot, Mark Ghate, Deepta |
author_sort | Gagrani, Meghal |
collection | PubMed |
description | PURPOSE: Glaucoma patients with peripheral vision loss have in the past subjectively described their field loss as ‘blurred’ or ‘no vision compromise’. We developed an iPad app for patients to self-characterise perception within areas of glaucomatous visual field loss. METHODS: Twelve glaucoma patients with visual acuity ≥20/40 in each eye, stable and reliable Humphrey Visual Field (HVF) over 2 years were enrolled. An iPad app (held at 33 cm) allowed subjects to modify ‘blur’ or ‘dimness’ to match their perception of a 2×2 m wall-mounted poster at 1 m distance. Subjects fixated at the centre of the poster (spanning 45° of field from centre). The output was degree of blur/dim: normal, mild and severe noted on the iPad image at the 54 retinal loci tested by the HVF 24-2 and was compared to threshold sensitivity values at these loci. Monocular (Right eye (OD), left eye (OS)) HVF responses were used to calculate an integrated binocular (OU) visual field index (VFI). All three data sets were analysed separately. RESULTS: 36 HVF and iPad responses from 12 subjects (mean age 71±8.2y) were analysed. The mean VFI was 77% OD, 76% OS, 83% OU. The most common iPad response reported was normal followed by blur. No subject reported dim response. The mean HVF sensitivity threshold was significantly associated with the iPad response at the corresponding retinal loci (For OD, OS and OU, respectively (dB): normal: 23, 25, 27; mild blur: 18, 16, 22; severe blur: 9, 9, 11). On receiver operative characteristic (ROC) curve analysis, the HVF retinal sensitivity cut-off at which subjects reported blur was 23.4 OD, 23 OS and 23.3 OU (dB). CONCLUSIONS: Glaucoma subjects self-pictorialised their field defects as blur; never dim or black. Our innovation allows translation of HVF data to quantitatively characterise visual perception in patients with glaucomatous field defects. |
format | Online Article Text |
id | pubmed-8788032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87880322022-02-07 What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss Gagrani, Meghal Ndulue, Jideofor Anderson, David Kedar, Sachin Gulati, Vikas Shepherd, John High, Robin Smith, Lynette Fowler, Zachary Khazanchi, Deepak Nawrot, Mark Ghate, Deepta Br J Ophthalmol Clinical Science PURPOSE: Glaucoma patients with peripheral vision loss have in the past subjectively described their field loss as ‘blurred’ or ‘no vision compromise’. We developed an iPad app for patients to self-characterise perception within areas of glaucomatous visual field loss. METHODS: Twelve glaucoma patients with visual acuity ≥20/40 in each eye, stable and reliable Humphrey Visual Field (HVF) over 2 years were enrolled. An iPad app (held at 33 cm) allowed subjects to modify ‘blur’ or ‘dimness’ to match their perception of a 2×2 m wall-mounted poster at 1 m distance. Subjects fixated at the centre of the poster (spanning 45° of field from centre). The output was degree of blur/dim: normal, mild and severe noted on the iPad image at the 54 retinal loci tested by the HVF 24-2 and was compared to threshold sensitivity values at these loci. Monocular (Right eye (OD), left eye (OS)) HVF responses were used to calculate an integrated binocular (OU) visual field index (VFI). All three data sets were analysed separately. RESULTS: 36 HVF and iPad responses from 12 subjects (mean age 71±8.2y) were analysed. The mean VFI was 77% OD, 76% OS, 83% OU. The most common iPad response reported was normal followed by blur. No subject reported dim response. The mean HVF sensitivity threshold was significantly associated with the iPad response at the corresponding retinal loci (For OD, OS and OU, respectively (dB): normal: 23, 25, 27; mild blur: 18, 16, 22; severe blur: 9, 9, 11). On receiver operative characteristic (ROC) curve analysis, the HVF retinal sensitivity cut-off at which subjects reported blur was 23.4 OD, 23 OS and 23.3 OU (dB). CONCLUSIONS: Glaucoma subjects self-pictorialised their field defects as blur; never dim or black. Our innovation allows translation of HVF data to quantitatively characterise visual perception in patients with glaucomatous field defects. BMJ Publishing Group 2022-02 2020-11-27 /pmc/articles/PMC8788032/ /pubmed/33218992 http://dx.doi.org/10.1136/bjophthalmol-2020-317034 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Clinical Science Gagrani, Meghal Ndulue, Jideofor Anderson, David Kedar, Sachin Gulati, Vikas Shepherd, John High, Robin Smith, Lynette Fowler, Zachary Khazanchi, Deepak Nawrot, Mark Ghate, Deepta What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss |
title | What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss |
title_full | What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss |
title_fullStr | What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss |
title_full_unstemmed | What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss |
title_short | What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss |
title_sort | what do patients with glaucoma see: a novel ipad app to improve glaucoma patient awareness of visual field loss |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788032/ https://www.ncbi.nlm.nih.gov/pubmed/33218992 http://dx.doi.org/10.1136/bjophthalmol-2020-317034 |
work_keys_str_mv | AT gagranimeghal whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT nduluejideofor whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT andersondavid whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT kedarsachin whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT gulativikas whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT shepherdjohn whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT highrobin whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT smithlynette whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT fowlerzachary whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT khazanchideepak whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT nawrotmark whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss AT ghatedeepta whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss |